gvtcx

Meningitis B Vaccine (2026)

key details

Statuscomplete
RegionLondon
Proceduredirect
OCIDocds-h6vhtk-059678

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is ·.

SupplierValueDateStatus
GLAXOSMITHKLINE UK LIMITED £1 21 May 2026 pending
GLAXOSMITHKLINE UK LIMITED · · active

description

The provision of a vaccine to protect against meningococcal B (MenB) disease, to be used in the national childhood immunisation programme, as well as a targeted programme to protect at risk adults against Gonorrhoea.

Value - The contract value is withheld from publication pursuant to regulation 94(2)(b) of the Procurement Act 2023, so as not to prejudice the legitimate commercial interest of the supplier.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
23 May 2025 Pipeline notice (UK1) Procurement Act 2023 026454-2025
9 Sept 2025 Transparency notice (UK5) Procurement Act 2023 054928-2025
22 May 2026 Contract award (UK6) Procurement Act 2023 048141-2026
30 Jun 2026 Contract details (UK7) Procurement Act 2023 061108-2026

more from Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.